Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
JAMA Dermatology|January 25, 2023
Association of Lipid-Lowering Drugs With Risk of Psoriasis: A Mendelian Randomization StudySizheng Steven Zhao, Zenas Z N Yiu, Anne Barton, et al.
The Journal of Dermatological Treatment|November 27, 2014
Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomesZenas Z N Yiu, Richard B Warren, Ulrich Mrowietz, et al.
Rheumatology (Oxford, England)|November 15, 2023
The predictive accuracy of cardiovascular disease risk prediction tools in inflammatory arthritis and psoriasis: an observational validation study using the Clinical Practice Research DatalinkDavid M Hughes, Jose Ignacio Cuitun Coronado, Pieta Schofield, et al.
JAMA Dermatology|May 31, 2023
Biosimilars for the Treatment of Psoriasis: A Systematic Review of Clinical Trials and Observational StudiesDuc Binh Phan, Sarah Elyoussfi, Michael Stevenson, et al.
Health Technology Assessment (Winchester, England)|February 12, 2024
Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitisSteven J Edwards, Charlotta Karner, Tracey Jhita, et al.
Pharmacoeconomics|July 8, 2026
Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling MethodsThomas S Clemmet, Duc Binh Phan, Alice Copson, et al.
Skin Health and Disease|June 1, 2026
Association between prescribed antidepressant medication and skin cancer (melanoma, basal cell carcinoma and cutaneous squamous cell carcinoma) risk: a systematic review and meta-analysisTabassum Rahman, Mikolaj Swiderski, Zoe C Venables, et al.
JAMA Dermatology|June 4, 2025
Adalimumab Monotherapy vs Adalimumab With Methotrexate for PsoriasisZenas Z N Yiu, Catherine H Smith, Philip Laws, et al.
The British Journal of Dermatology|June 27, 2025
Incidence rates of bullous pemphigoid, herpes zoster, and urticaria following the start of the COVID-19 vaccination programme in the UK: a population-based cohort studyMikolaj Swiderski, Sarah Lewis, Yana Vinogradova, et al.
The British Journal of Dermatology|January 10, 2025
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
Pageof 6